Can States Regulate Prescription Drug Costs? Questions and Answers About NASHP’s Rate-Setting Model Legislation
The National Academy for State Health Policy’s (NASHP) has crafted model legislation – called the Prescription Drug Rate-Setting Model Act – that states can use to regulate drug costs. The legislation creates a drug cost review commission that evaluates the affordability of certain drugs in the same way that states now regulate Medicaid, state employee […]
On Friday, Oct. 13, 2017,the Trump Administration announced it would no longer make cost-sharing reduction (CSR) payments to insurers offering coverage on health insurance marketplaces. The announcement cited guidance from the US Department Justice that questioned the legality of the appropriation for these payments (for more Cost Sharing Reduction Debate: Why This Matters and How […]
Congress missed the Sept. 30, 2017, deadline to extend federal funding for the Children’s Health Insurance Program (CHIP), so there is currently no new or guaranteed future federal support for the program that covers an estimated 9 million children. There are two proposed bills to reauthorize CHIP – the Senate’s KIDS Act of 2017 and […]
The National Academy for State Health Policy (NASHP) has awarded $300,000 in grants to Colorado, Delaware, and Oklahoma to help the states develop innovative policy solutions to tackle high prescription drug prices. With the support from the Laura and John Arnold Foundation, the funding enables states to explore promising policy approaches to control rapidly escalating […]
States Could Gain More Flexibility to Manage Medicaid Programs — What Can They Learn from the 1990s AFDC Flexibility Experience?
The new Administration has signaled a willingness to give states more flexibility to address health and prevention in new and innovative ways under Section 1115 of the Social Security Act. This provision allows the Department of Health and Human Services to approve experimental and innovative projects that promote the goals of Medicaid. This comes at […]